BiP (Kar2 in yeast) is an essential Hsp70 chaperone and master regulator of endoplasmic reticulum (ER) function. BiP's activity is regulated by its intrinsic ATPase activity that can be stimulated by two different nucleotide exchange factors, Sil1 and Lhs1. Both Sil1 and Lhs1 are glycoproteins, but how N-glycosylation regulates their function is not known. Here, we show that N-glycosylation of Sil1, but not of Lhs1, is diminished upon reductive stress. N-glycosylation of Sil1 is predominantly Ost3-dependent and requires a functional Ost3 CxxC thioredoxin motif. N-glycosylation of Lhs1 is largely Ost3-independent and independent of the CxxC motif. Unglycosylated Sil1 is not only functional but is more effective at rescuing loss of Lhs1 activity than N-glycosylated Sil1. Furthermore, substitution of the redox active cysteine pair C52 and C57 in the N terminus of Sil1 results in the Doa10-dependent ERAD of this mutant protein. We propose that reductive stress in the ER inhibits the Ost3-dependent N-glycosylation of Sil1, which regulates specific BiP functions appropriate to the needs of the ER under reductive stress.
BiP (Kar2 in yeast) is an essential Hsp70 chaperone and master regulator of endoplasmic reticulum (ER) function. BiP's activity is regulated by its intrinsic ATPase activity that can be stimulated by two different nucleotide exchange factors, Sil1 and Lhs1. Both Sil1 and Lhs1 are glycoproteins, but how N-glycosylation regulates their function is not known. Here, we show that N-glycosylation of Sil1, but not of Lhs1, is diminished upon reductive stress. N-glycosylation of Sil1 is predominantly Ost3-dependent and requires a functional Ost3 CxxC thioredoxin motif. N-glycosylation of Lhs1 is largely Ost3-independent and independent of the CxxC motif. Unglycosylated Sil1 is not only functional but is more effective at rescuing loss of Lhs1 activity than N-glycosylated Sil1. Furthermore, substitution of the redox active cysteine pair C52 and C57 in the N terminus of Sil1 results in the Doa10-dependent ERAD of this mutant protein. We propose that reductive stress in the ER inhibits the Ost3-dependent N-glycosylation of Sil1, which regulates specific BiP functions appropriate to the needs of the ER under reductive stress.
he endoplasmic reticulum (ER) is a major site of protein and lipid biogenesis. Proteins that function within the secretory pathway, or are secreted, are translocated into the ER as unfolded polypeptide chains where they can be N-glycosylated or form disulphide bonds to adopt their mature structures. Fully matured proteins are subsequently transported from the ER to their appropriate destinations. These processes are closely monitored by the ER quality control apparatus to prevent protein aggregation and maintain homeostasis.
The Hsp70 ortholog BiP (Kar2 in yeast) is essential for ER homeostasis, where it acts as a chaperone to promote productive protein folding (1) (2) (3) (4) (5) . Kar2 activity is regulated by two classes of coregulators; Hsp40/DnaJ-like proteins stimulate ATP hydrolysis, whereas nucleotide exchange factors (NEFs) promote ADP release (6, 7) . Together they promote Kar2 activity by allowing it to undergo multiple cycles of substrate binding and release. Cells possess several mechanisms that regulate Kar2 activity to buffer against fluctuations in the ER folding capacity and prevent protein misfolding during ER stress.
ER function relies on the maintenance of an appropriate redox balance. Upon increased ER oxidation, a highly conserved cysteine residue, C63, within the ATPase domain of BiP becomes oxidized (8, 9) . This alters BiP/Kar2 chaperone activity to limit polypeptide aggregation during suboptimal redox conditions for ER protein folding (9) (10) (11) . Reductive stress also gives rise to the accumulation of misfolded proteins. However, little is known regarding the mechanisms that exist to regulate BiP activity during reductive stress, for instance during extensive oxidative protein folding in secretory cells such as pancreatic acinar cells (12) .
Here, we show that reductive ER stress diminishes N-glycosylation of the Kar2 NEF Sil1, but not of Lhs1. N-glycosylation of Sil1 is entirely Ost3-dependent and requires a functional CxxC thioredoxin motif. N-glycosylation of Lhs1 is partially Ost3-dependent and independent of the CxxC motif. The unglycosylated Sil1 variant (uSil1) retains functionality and is able to substitute for Lhs1 activity more effectively than its cognate N-glycosylated derivative. We propose that the N-glycosylation status of Sil1 directs the NEF to coordinate specific Kar2-regulated activities to suit the needs of the ER when in a state of reductive stress.
Results

N-Linked Glycosylation of the Sil1 Nucleotide Exchange Factor, but
Not of Lhs1, Is Diminished by Reductive Stress. Environmental stress can vary the load of unfolded or misfolded proteins in the ER, so BiP/Kar2 and its effectors must be available and appropriately active in times of need to maintain ER homeostasis. In yeast, treatment with the reductant DTT or the N-glycosylation inhibitor tunicamycin (Tm) increases expression of Kar2 and its NEFs Lhs1 and Sil1 (13) . This correlates with an increase in both Sil1 and Lhs1 at the protein level (Fig. 1A) . Both Lhs1 and Sil1 are N-glycosylated in vegetative cells, and their N-glycosylation is perturbed in cells treated with Tm (Fig. 1A) . However, we also observed accumulation of unglycosylated Sil1 (uSil1) in cells treated with DTT (Fig. 1A) . Protease protection analysis ruled out the possibility that cytoplasmic pre-Sil1, rather than uSil1, accumulates in DTT-treated cells (Fig. S1A) . Also, the predominant form of Sil1 that accumulates upon DTT treatment was not a substrate for the N-glycan-binding lectin Con A (Fig. S1B) . In Significance Endoplasmic reticulum (ER) function relies on the maintenance of an appropriate redox balance. We observe that ER reductive stress is sensed through the oligosaccharyltransferase subunit Ost3 and acts to inhibit glycosylation of Sil1. Misfolded proteins accumulate within the ER under reductive stress and may sequester Lhs1 and limit the pool of free Lhs1 that can function as a BiP nucleotide exchange factor. Furthermore, unglycosylated Sil1 can compensate for the loss of Lhs1 activity more readily than glycosylated Sil1. Accumulation of unglycosylated Sil1 upon reductive stress may therefore be an adaptive mechanism that allows Sil1 to compensate for loss of Lhs1 NEF activity under these conditions. contrast to Sil1, treatment with DTT did not affect glycosylation of Lhs1 (Fig. 1A) . This suggested that uSil1 specifically accumulated upon DTT-induced ER stress.
As a reductant, DTT disrupts the redox balance of the ER. The essential Ero1 protein is a thiol oxidase that maintains the ER redox balance required to promote oxidative protein folding in this organelle (14) (15) (16) . To confirm that Sil1 N-glycosylation is perturbed as a consequence of general ER reductive stress rather than by DTT alone, we investigated Sil1 glycosylation in cells treated with the Ero1 inhibitor 1-bromo-5-methoxy-2,4-dinitrobenzene (Erodoxin) (17) . We observe a similar N-glycosylation profile of Sil1 and Lhs1 in cells treated with Erodoxin to that observed in cells treated with DTT, with accumulation of uSil1 but maintenance of efficiently glycosylated Lhs1 (Fig. 1B) . In contrast to treatments that induce reductive stress, treatment of cells with hydrogen peroxide to impose oxidative stress had no effect on glycosylation of Sil1 or Lhs1 (Fig. 1C) .
The burden of reductive stress induces the unfolded protein response (UPR). We therefore investigated whether Sil1 N-glycosylation is perturbed in cells in which the UPR is induced by other means. For this, we starved cells of inositol and/or constitutively overexpressed Hac1 I . Inositol depletion activates the UPR by disrupting phospholipid homeostasis, while Hac1 I is the direct transcriptional activator of the UPR (18, 19) . Independent or concurrent inositol depletion or Hac1 I overexpression strongly induced the UPR (Fig. S1C) . Consistent with UPR induction, Sil1 protein levels were substantially increased in inositol-starved cells (Fig. 1D ) or cells expressing Hac1 I (Fig. 1E ) compared with control cells. However, Sil1 N-glycosylation was not perturbed by either inositol starvation (Fig. 1D) or Hac1 I expression (Fig. 1E ). We next tested if inhibition of Sil1 N-glycosylation by reductive stress required a functional UPR. uSil1 accumulated in cells treated with DTT with or without the UPR activator Ire1 (ire1Δ) (Fig. 1F) . Therefore, Sil1 N-glycosylation is not perturbed by general ER stress, but instead is specifically hypersensitive to the redox potential of the ER lumen.
N-Glycosylation of Sil1 Is Ost3-Dependent. Oligosaccharyltransferase (OST) acts at the confluence of protein modification and protein folding. Yeast OST is comprised of eight protein subunits: Ost1, Ost2, Ost4, Ost5, Stt3, Swp1, Wbp1, and either Ost3 or Ost6 (20) (21) (22) (23) . Ost3 and Ost6 are paralogues, each with distinct substrate specificities, and the incorporation of either into OST defines two isoforms of the enzyme (24) . The lumenal domain of both Ost3 and Ost6 possesses a CxxC thioredoxin-like motif, and their redox-dependent peptide binding activities increase the glycosylation efficiency of distinct sites in protein substrates (24) . We sought to determine the dependence of Lhs1 and Sil1 N-glycosylation on OST with either Ost3 or Ost6. N-glycosylation of both Lhs1 and Sil1 was not affected in Ost6-deficient cells (ost6Δ) (Fig. 2A) . In contrast, Sil1 was essentially completely unglycosylated in ost3Δ cells, indicating that N-glycosylation of Sil1 was predominantly Ost3-dependent ( Fig. 2A) . ost3Δ cells also accumulated a form of Lhs1, termed g* Lhs1, with a greater electrophoretic mobility than WT but less than that in cells treated with Tm ( Fig. 2A) . Importantly, no further reduction in glycosylation of Lhs1 was observed in ost3Δ cells treated with DTT. This indicated that while N-glycosylation of at least one site in Lhs1 is Ost3-dependent, only Sil1 N-glycosylation is Ost3-dependent and redox sensitive.
The redox sensitivity of Sil1 N-glycosylation suggested the involvement of the Ost3 CxxC thioredoxin-like motif. To test this, we investigated Sil1 N-glycosylation in ost3Δ cells expressing Ost3 or a redox inactive variant of Ost3 in which both cysteine residues of the CxxC motif were replaced with serines (ost3 C→S ). N-glycosylation of Sil1 in ost3Δ cells was effectively restored by expression of OST3 but not with ost3 C→S (Fig. 2B ). In contrast, N-glycosylation of Lhs1 was restored in cells expressing either OST3 or ost3 C→S (Fig. 2B ). This confirms that Sil1 N-glycosylation requires the oxidoreductase activity of the Ost3-containing OST in vivo and that Sil1 N-glycosylation is exquisitely sensitive to the redox status of the ER lumen.
The transient binding of nascent polypeptide to Ost3 and Ost6 proceeds noncovalently or through mixed disulphides and is necessary to inhibit local protein folding to increase N-glycosylation efficiency of substrates (24, 25) . The Sil1 protein possesses four cysteine residues (C52, 57, 203, and 373) and six potential Nglycosylation sites (N105, 181, 215, 233, 315, and 333). Sil1 Nglycosylation was not affected by substitution of either C52, C57, C203, or C373 with either alanine or serine (Fig. 2C ). This was surprising given that Sil1 N-glycosylation is perturbed by reductive stress. Furthermore, the accumulation of uSil1 observed following . For control, cells were treated with 10 μg/mL Tm.
DTT treatment was not diminished by substitution of either C52, C57, C203, or C373 with either alanine or serine (Fig. S2A) . Therefore, the Ost3-dependence of Sil1 N-glycosylation is not bypassed by elimination of a cysteine in Sil1. Glutamine scanning mutagenesis of each potential sequon identified that Sil1 Nglycosylation was only disrupted following substitution of N181 (Fig. 2D) . Previous studies have shown that disruption of the Ost3 thioredoxin motif only affects the N-glycosylation of a small subset of substrates (24) . That no cysteine residue within Sil1 is necessary for N-glycosylation rules out the possibility that reductive stress ablates formation of a mixed disulphide between Ost3 and Sil1. Rather, our data best supports a model in which the substrate-binding domain of Ost3 undergoes a sufficient redoxdependent structural change so that the Sil1 nascent polypeptide is no longer recognized as being a substrate, as has been reported in vitro for model Ost3/Ost6 substrates (24, 25) .
Upon further inspection, we realized that Sil1 C52S C57S had undergone a series of posttranslational modification giving rise to protein laddering (Fig. S2B) . Such "laddering" is a hallmark of protein polyubiquitination and occurs when ER resident proteins are targeted for ER-associated degradation (ERAD). To investigate whether Sil1 C52S C57S is turned over, we investigated the stability of Sil1 C52S C57S and WT Sil1 in cells by cycloheximide (chx) chase analysis. Sil1 protein levels remained constant throughout the 90-min chx chase ( Fig. 3 A and B) . In contrast, the Sil1 C52S C57S protein was more labile as levels diminished throughout the chx chase ( Fig. 3 A and B) . We next investigated whether Sil1 C52S C57S is degraded via ERAD. DOA10, and HRD1/DER3 encode for the two major ER resident E3 ligases Doa10 and Hrd1 in yeast (26) (27) (28) . Deletion of DOA10 (doa10Δ) led to an almost complete stabilization of the Sil1 C52S C57S protein ( Fig. 3 C and D) . Furthermore, expression of SIL1
C52S C57S
severely diminished the growth of doa10Δ yeast (Fig. 3E) . In contrast, deletion of HRD1 (hrd1Δ) had no detectable effect on Sil1 C52S C57S protein stability (Fig. 3 C and D) , and expression of SIL1 C52S C57S did not affect hrd1Δ cellular growth (Fig. 3E) . Deletion of the HRD3 (hrd3Δ) structural gene, which encodes for the Hrd3 component of the HRD complex, also had no detectable effect on Sil1 C52S C57S protein stability (Fig. 3 C and D) . A role for Doa10 in the degradation of ERAD-L substrates has not been described previously. However, Doa10 has been shown to be required for the degradation of the ERAD-M substrate Sbh2 (29) 
N181Q were transformed into JTY65 {sil1Δ::kanMX4 lhs1Δ:: kanMX4 [pRC43 (LHS1, URA3)]} (33) and tested for the ability of these strains to grow after loss of pRC43 on 5-fluoroorotic acid (5-FOA) medium. Strains harboring either SIL1 or SIL1 N181Q produced viable colonies, whereas cells transformed with vector alone could not (Fig. 4A ). This confirmed that unglycosylated Sil1 was functional.
Overexpression of SIL1 suppresses the severe growth defect of ire1Δ lhs1Δ double mutant cells (33) . We therefore tested whether overexpression of the SIL1 N181Q N-glycosylation mutant was able to suppress this growth defect. We transformed YEp SIL1 and YEp SIL1 N181Q into JTY62 {ire1Δ::kanMX4 lhs1Δ:: kanMX4 [pJT40 (LHS1, ADE3, URA3)]} and tested the ability of these strains to grow after loss of pJT40 on 5-FOA medium. Again, we observed that overexpression of SIL1 partially suppresses the severe growth defect of ire1Δ lhs1Δ double mutant cells. Surprisingly, overexpression of SIL1 N181Q allowed a more impressive suppression of this growth defect (Fig. S3A) . This suggested that under these conditions, uSil1 may compensate for the loss of Lhs1 activity more readily than gSil1. Next, we tested if only modest overexpression of unglycosylatable SIL1 N181Q was sufficient to rescue the growth defect of ire1Δ lhs1Δ cells. This was indeed the case, with low copy expression of SIL1 N181Q from centrimeric plasmid YCp sufficient to promote growth of JTY62 yeast after induced loss of plasmid-borne LHS1 expression on 5-FOA medium (Fig. S3B) . Expression of SIL1 in the same system only allowed poor growth (Fig. S3B ). Given the extent to which low copy expression of SIL1 N181Q was able to promote growth of JTY62 yeast after induced loss of plasmidborne LHS1 expression on 5-FOA medium, we tested if expression of SIL1 N181Q as the only source of SIL1 was sufficient to rescue the growth defect of ire1Δ lhs1Δ cells. A SIL1 N181Q integration cassette containing the LEU2 selectable marker was integrated into the SIL1 genetic locus by homologous recombination, and successful substitution was confirmed by sequencing and immunoblot ( Fig. S3 C and D) . Genomic substitution of SIL1 with SIL1 N181Q ::LEU2 was sufficient to promote growth of JTY62 yeast after induced loss of plasmid-borne LHS1 expression on 5-FOA medium (Fig. 4B ). Together, this shows that unglycosylated Sil1 can compensate for the loss of Lhs1 activity more readily than glycosylated Sil1.
The accumulation of unglycosylated Sil1 upon reductive stress may be necessary to protect cells from this deleterious stress. To test this, we investigated whether low copy expression of SIL1 N181Q would reduce the hypersensitivity of ire1Δ cellular growth to DTT. The rationale for this is that in ire1Δ cells, the UPR cannot be induced, and cellular growth is sensitive to concentrations of DTT that negligibly affect Sil1 N-glycosylation. This is important as SIL1 expression is highly elevated upon UPR induction and would likely mask any beneficial effects of SIL1 N181Q expression. The relative growth of ire1Δ cells transformed with either YCp SIL1 or YCp SIL1 N181Q was determined in growth medium containing increasing concentrations of DTT (0.05-1 mM). We observed YCp SIL1 N181Q to bestow modest suppression of ire1Δ DTT hypersensitivity compared with YCp SIL1 (Fig. 4C) . We find the growth fitness of ire1Δ cells that express SIL1
N181Q to be ∼1.5× greater than those expressing SIL1 when exposed to 0.25-0.5 mM DTT (Fig. 4C) .
lhs1Δ cellular growth is also sensitive to concentrations of DTT that negligibly affect Sil1 N-glycosylation. Given that uSil1 can compensate for the loss of Lhs1 activity more readily than glycosylated Sil1, we were interested to determine whether expression of SIL1 N181Q would also reduce the hypersensitivity of lhs1Δ cellular growth to DTT. We observed SIL1 N181Q expression to partially suppress lhs11Δ DTT hypersensitivity as lhs1Δ SIL1 N181Q cell growth was greater than lhs1Δ SIL1 cells at all concentrations of DTT (0.1-1.6 mM) (Fig. 4D) . Cells under reductive stress may benefit from uSil accumulation simply because it is more stable than gSil1. We tested this by chx chase analysis in cells that had been acutely challenged with DTT for 1 h. We observed a steady decline in gSil1 protein levels, with ∼70% gSil1 remaining after 90-min chase (Fig. S4 A and B) . However, the decline in uSil1 protein levels over this time course was even more pronounced, with ∼40% uSil1 remaining after 90-min chase (Fig. S4 A and B) . uSil1 is therefore more labile than gSil1 under these conditions. As such, the increased ability of uSil1 to rescue the growth defect of ire1Δ lhs1Δ cells and to improve the fitness of ire1Δ grown in the presence of DTT is not due to its increased stability.
It has previously been shown that a sil1Δ strain exhibits improved survival in the presence of the cysteine oxidant diamide due in part due to the loss of Sil1 NEF activity allowing BiP to reside longer in an ADP/peptide-bound state, thus enhancing BiP's holdase activity (8, 9) . Given this, we hypothesized that overexpression of uSil1 would render cells hypersensitive to acute cysteine oxidation evoked by exposure to diamide. To test this, cells overexpressing either SIL1 or SIL1 N181Q were either mock treated or exposed to 10 mM diamide for either 1 or 2 h and cell viability was determined following an 8-h recovery in rich media. Indeed, SIL1
N181Q overexpressing cells were more sensitive to the deleterious effects of diamide, as after 1-or 2-h exposure to 10 mM diamide, ∼100× or 1,000× fewer SIL1 N181Q overexpressing cells were recovered relative to cells overexpressing SIL1 (Fig. 4E) . Discussion N-Glycosylation Enables Sil1 Functional Specialization. N-glycosylation and protein folding are intimately linked in the ER. Here, we show that ER reductive stress sensed through Ost3 acts to inhibit glycosylation of Sil1, which increases Sil1's activity as a suppressor of loss of Lhs1. Efficient N-glycosylation under nonstressed conditions is therefore a negative regulator of some aspects of Sil1 function. Genetic or chemical inhibition of N-glycosylation results in widespread underglycosylation of diverse proteins, generally resulting in loss of protein folding efficiency, stability, and function. In contrast, loss of glycosylation of Sil1 results in a gain of function whereby uSil1 is a better Lhs1 substitute than its cognate glycosylated derivative.
It is not obvious how loss of N-glycosylation would alter Sil1 function. The crystal structure of Sil1 shows that N181 is located on the opposite face of Sil1 to the surface that mediates interaction with Kar2 (34). Lack of glycosylation would therefore be unlikely to directly impact interactions between Sil1 and Kar2. However, loss of glycosylation could alter Sil1 structure, flexibility, or dynamics in ways that alter this interaction or that regulate Sil1's NEF activity. It is also possible that loss of glycosylation at N181 specifically impacts interactions between Sil1 and other proteins.
Although Sil1 and Lhs1 are functionally related, they are not entirely interchangeable, as some mutant phenotypes remain upon cross-complementation even with high levels of overexpression. Genetic interaction networks are distinct for lhs1Δ and sil1Δ cells (17, (35) (36) (37) (38) (39) (40) (41) (42) (43) (44) (45) , further suggesting Lhs1 and Sil1 have some specialized function(s). We consider the N-glycosylation of Sil1 to be an important factor that enables regulation of such functional specialization. For example, Lhs1 can also act as an ATP-independent holdase, binding to misfolded proteins to prevent them from aggregating (46) (47) (48) . The accumulation of misfolded proteins in the ER under reductive stress may sequester Lhs1 and limit the pool of free Lhs1 that can function as a NEF. Given that uSil1 is a better substitute for Lhs1, accumulation of unglycosylated Sil1 upon reductive stress may allow Sil1 to either compensate for loss of Lhs1 NEF activity or to N181Q were grown to midlog phase. One OD 600 of cells were incubated with and without 10 mM diamide for 60 and 120 min. Afterward, cells were isolated and washed twice with 5 mL ddH 2 O and then recovered in YPD for 8 h. Cells were spotted in a 10-fold dilution series and grown at 30°C for 2 d.
bolster NEF activity in ER functions coordinated by Lhs1 under these conditions. Sil1, a Redox-Dependent ERAD Substrate? It is the accepted model that ERAD-L substrates are exclusively recognized by the Hrd1 complex, and ERAD-C substrates by the Doa10 complex (29, (49) (50) (51) (52) (53) . As Sil1 does not possess a transmembrane domain, we predicted Sil1 C52S C57S would be a Hrd1-dependent ERAD-L substrate. However, the supposition that ERAD-L and ERAD-C substrates are exclusively recognized by the Hrd1 complex and Doa10 complex, respectively, is derived from analysis of a limited number of ERAD substrates. Our observation that ERAD of Sil1 C52S C57S is Doa10-dependent suggests that this model is incomplete, and there may well be more unidentified Doa10-dependent ER lumenal substrates. Another possibility is that membrane association of lumenal proteins can drive Doa10-dependent ERAD. It has recently been shown that Doa10 is required for degradation of the ERAD-M substrate Sbh2 (29) . Sbh2 is the first characterized Doa10 substrate for which its TM domain and short ER-lumenal domain can target the protein for Doa10-dependent degradation (29) . It is possible that Sil1 associates predominantly with the lumenal face of the ER membrane, and it is this association that enables Sil1 C52S C57S to be a Doa10 ERAD substrate. We attempted to test if N-glycosylation is necessary for Doa10-dependent ERAD of Sil1 C52S C57S
, but the pool of uSil1 C52S C57S that accumulates upon tunicamycin treatment undergoes rapid additional posttranslational modification, making analysis impossible (Fig. S2C) . However, uSil1 turnover is faster than gSil1 in DTT-treated cells, showing that N-glycosylation is not required for Sil1 turnover.
Residues C52 and C57 of Sil1 have recently been shown to form a redox-active cysteine pair that facilitates the reduction of C63 in the ATPase domain of Kar2 (8) . Oxidation of C63 impairs Kar2's ATPase activity, altering its chaperone function to cope with the suboptimal folding conditions that arise during oxidative stress (8) (9) (10) (11) . Sil1 can then reduce the oxidized cysteine residue in the BiP ATPase domain to restore ATPase activity and chaperone function once the levels of oxidative stress in the ER have subsided. Inappropriate reduction of Kar2 C63 by Sil1 under oxidative stress would therefore be undesirable. Our observation that Sil1 C52S, C57S is an ERAD substrate suggests that Sil1 degradation is redox-dependent, with the Sil1 C52S, C57S variant simulating the Sil1 N terminus in its fully reduced state. In addition, we frequently observe Sil1 turnover to be more pronounced in DTTtreated cells relative to control. The redox-dependent degradation of Sil1 may therefore appropriately limit the amount of Sil1 that has the potential to reduce C63 in the ATPase domain of Kar2/ BiP, such as when Kar2 is required to function as a holdase.
Concluding Remarks
With their ER-lumenal thioredoxin-like domains, the Ost3 and Ost6 subunits of OST integrate protein modification and protein folding of diverse substrates across the cellular glycoproteome. Our discovery that the redox status of Ost3 controls the Nglycosylation of the ER lumenal Sil1 nucleotide exchange factor also places this OST subunit at the heart of ER protein folding homeostasis. Based on our data, we propose a model in which ER reductive stress reduces the Ost3 CxxC motif, inhibiting N-glycosylation of Sil1 to modulate its activity such that Kar2 function can be tailored to suit the needs of the ER. Furthermore, the apparent hypersensitivity of Sil1 N-glycosylation to reductive stress may provide a simple assay to monitor the redox environment of the ER.
Materials and Methods
Strain and Growth Conditions. Saccharomyces cerevisiae strains are listed in Table S1 , and plasmids are listed in Table S2 . Yeast strains were grown routinely at 30°C in YP medium (2% peptone, 1% yeast extract) containing 2% glucose (YPD) or in minimal medium (0.67% yeast nitrogen base; YNB) with 2% glucose plus appropriate supplements for selective growth. All media were from Difco Laboratories. Yeast transformations and 5-FOA counterselection of URA3 cells were carried out as described previously (54) . Cell density in liquid culture was monitored by A 600 using an Eppendorf Biophotometer.
Immunoblotting. Whole yeast extracts were prepared by glass bead lysis in SDS sample buffer from cultures grown to mid-log phase, resolved by SDS/PAGE, transferred to a nitrocellulose membrane (Bio-Rad), and probed with either αLhs1, αKar2, or αSil1 antiserum whose production has been described previously (33) . These antibodies were used at the dilutions indicated in parentheses for immunoblotting: Lhs1 (sheep, 1:10000), Kar2 (sheep, 1:10000), Sil1 (sheep, 1:5000) peroxidase-conjugated goat anti-sheep IgG (1:10000; Sigma). Immunoreactive species were visualized using Clarity (Bio-Rad), and protein degradation rates were determined using a ChemiDoc imaging system (Bio-Rad) and Image Lab software (Bio-Rad).
Chx Chase Analyses. Chx chase analyses were performed according to Habeck et al. (29) . Briefly, 0.25 mg/mL chx was added to log-phase yeast cultures, and cell aliquots were removed at the indicated times after addition. Cells were harvested by centrifugation and resuspended in ice cold 10 mM NaN 3 . After preparation of lysates, proteins were separated by SDS/PAGE and immunodetection was performed as described above.
